RECRUITINGOBSERVATIONAL
World Bleeding Disorders Registry
About This Trial
The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to collect uniform and standardized patient data and guide clinical practice. With informed consent from the patient, the WBDR stores anonymous data about the person's disease, such as hemophilia type and severity, symptoms, and treatment.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients of participating Hemophilia Treatment Centres with Hemophilia A or B, or von Willebrand Disease
Who Should NOT Join This Trial:
- none
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients of participating Hemophilia Treatment Centres with Hemophilia A or B, or von Willebrand Disease
Exclusion Criteria:
* none
Locations (1)
World Federation of Hemophilia
Montreal, Quebec, Canada